Showing results (1-10 of 344) with videos related to
Sort By:
Pageof 35
Liver International : Official Journal of the International Association for the Study of the Liver|March 4, 2016
Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?Roberta D'Ambrosio, Massimo ColomboDigestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 5, 2013
Safety of direct antiviral agents in real lifeRoberta D'Ambrosio, Massimo ColomboExpert Opinion on Drug Safety|February 4, 2015
Assessing safety and efficacy of sofosbuvir for the treatment of hepatitis CRoberta D'Ambrosio, Alessio Aghemo, Massimo ColomboBiologics : Targets & Therapy|November 3, 2012
Treatment of experienced and naïve patients with hepatitis C: focus on telaprevirRoberta D'Ambrosio, Alessio Aghemo, Massimo ColomboInternational Journal of Molecular Sciences|August 22, 2015
Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C TherapyRoberta D'Ambrosio, Cristina Della Corte, Massimo ColomboCurrent Opinion in Virology|April 19, 2017
Direct-acting antivirals: the endgame for hepatitis C?Roberta D'Ambrosio, Elisabetta Degasperi, Massimo Colombo, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2016
Sofosbuvir-based regimens for the treatment of hepatitis C virus in patients who underwent lung transplant: case series and review of the literatureRoberta D'Ambrosio, Alessio Aghemo, Valeria Rossetti, et al.Viral Immunology|April 18, 2018
Chemokine Receptor 5 Has No Major Role in the Severity of Hepatitis C Virus-Related Liver DamageGiuseppe Colucci, Roberta D'Ambrosio, Enrico Galmozzi, et al.Antiviral Therapy|November 21, 2007
Lack of rapid virological response predicts interferon-alpha2b/ribavirin therapy failure in HCV genotype 2 patients: a single-centre studyMaria Grazia Rumi, Alessio Aghemo, Roberta D'Ambrosio, et al.Antiviral Therapy|July 7, 2009
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotypeAlessio Aghemo, Maria Grazia Rumi, Sara Monico, et al.Pageof 35